0001209191-22-007065.txt : 20220203 0001209191-22-007065.hdr.sgml : 20220203 20220203195457 ACCESSION NUMBER: 0001209191-22-007065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wei Lin CENTRAL INDEX KEY: 0001872772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40602 FILM NUMBER: 22590425 MAIL ADDRESS: STREET 1: C/O ERASCA, INC. STREET 2: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Erasca, Inc. CENTRAL INDEX KEY: 0001761918 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831217027 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 465-6511 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-01 0 0001761918 Erasca, Inc. ERAS 0001872772 Wei Lin C/O ERASCA, INC. 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 0 1 0 0 Chief Medical Officer Common Stock 2022-02-01 5 J 0 E 1562 11.6025 A 314062 D Stock Option (Right to Buy) 11.54 2022-02-01 4 A 0 272100 0.00 A 2032-01-31 Common Stock 272100 272100 D Includes 1,562 shares acquired under the Erasca, Inc. employee stock purchase plan on December 15, 2021. 1/48th of the shares subject to the option vest monthly following February 2, 2022, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. /s/ Ebun S. Garner, Attorney-in-Fact 2022-02-03